Related references
Note: Only part of the references are listed.Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes
Sebastiano A. Musumeci et al.
EXPERIMENTAL NEUROLOGY (2007)
Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression
Lingfei Hou et al.
NEURON (2006)
Current advances in local protein synthesis and synaptic plasticity
Brad E. Pfeiffer et al.
JOURNAL OF NEUROSCIENCE (2006)
Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome
ED Nosyreva et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders
RJ Mandel et al.
MOLECULAR THERAPY (2006)
Local translational control in dendrites and its role in long-term synaptic plasticity
MA Sutton et al.
JOURNAL OF NEUROBIOLOGY (2005)
Recombinant adeno-associated viral vectors in the nervous system
C Burger et al.
HUMAN GENE THERAPY (2005)
Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent longterm depression
ED Nosyreva et al.
JOURNAL OF NEUROSCIENCE (2005)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
C Burger et al.
MOLECULAR THERAPY (2004)
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
CS Peden et al.
JOURNAL OF VIROLOGY (2004)
Prospects for gene therapy in the fragile X syndrome
MC Rattazzi et al.
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2004)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
S Zolotukhin et al.
METHODS (2002)
Altered synaptic plasticity in a mouse model of fragile X mental retardation
KM Huber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Species-specific and isoform-specific RNA binding of human and mouse fragile X mental retardation proteins
RB Denman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
R Xu et al.
GENE THERAPY (2001)
CMV-β-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1α promoter and results in therapeutic levels of human factor X in mice
LF Xu et al.
HUMAN GENE THERAPY (2001)
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
AM Peier et al.
HUMAN MOLECULAR GENETICS (2000)
Fragile X syndrome at the turn of the century
RF Kooy et al.
MOLECULAR MEDICINE TODAY (2000)
Share Paper
